The Different Reduction Rate of Prostate-Specific Antigen in Dutasteride and Finasteride

PURPOSE: To compare and analyze the therapeutic effects and changes in the prostate-specific antigen (PSA) level with treatment with finasteride or dutasteride for benign prostatic hyperplasia (BPH) for 1 year. MATERIALS AND METHODS: We retrospectively investigated patients who suffered from BPH for...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Yong Hyeuk, Cho, Sung Yong, Cho, In Rae
Formato: Texto
Lenguaje:English
Publicado: The Korean Urological Association 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2963784/
https://www.ncbi.nlm.nih.gov/pubmed/21031091
http://dx.doi.org/10.4111/kju.2010.51.10.704

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2963784/
https://www.ncbi.nlm.nih.gov/pubmed/21031091
http://dx.doi.org/10.4111/kju.2010.51.10.704

Ejemplares similares